RDInvesting Provides Stocks Research on ImmunoCellular Therapeutics and Rosetta Genomics
Continue ReadingTag: analyst-reports
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
RDInvesting Provides Stocks Research on Ariad Pharmaceuticals and Infinity Pharmaceuticals
Continue Reading
Major Health Insurers Fall on Medicare Rate Cut Proposal
RDInvesting Provides Stock Research on Aetna and WellCare Health Plans
Continue Reading
Humana and UnitedHealth Group Shares Fall as Government Proposes Medicare Advantage Rate Cuts
RDInvesting Provides Stock Research on Humana and UnitedHealth Group
Continue Reading
Oil Industry to Benefit From Growing Global Oil Demand in 2013
Five Star Equities Provides Stock Research on VAALCO Energy and Gulfport Energy
Continue Reading
U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013
Five Star Equities Provides Stock Research on Patterson-UTI Energy and Cal Dive International
Continue Reading
Strong Earnings Season Drives S&P 500 Index to Five Year High
Five Star Equities Provides Stock Research on Lorillard and Philip Morris International
Continue Reading
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
RDInvesting Provides Stocks Research on Opko Health and Questcor Pharmaceuticals
Continue Reading
Solar Industry Impressing Investors With Gains in 2013 After a Dismal 2012
RDInvesting Provides Stock Research on Canadian Solar and JA Solar
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on DARA Biosciences and PDL BioPharma
Continue Reading